 activity osteoblast-like ROS cells OCT synthetic vitamin analog ability OH leukemia skin cells immune response PTH secretion calcemic activity mechanism selective action understood OCT diminished ability calcium bone vivo vitro findings contradictory Little effect OCT bone forming cells present studies actions OCT molecular level osteoblast-like cell line ROS vitamin receptor VDR intact cells rate OH OH time course specific binding OCT biphasic initial plateau increase Scatchard analysis exposure OH VDR fmol/mg protein fmol/mg protein Exposure increased VDR fmol/mg protein OCT capable up-regulating VDR ROS cells contrast affinity OCT VDR chick intestine cells Kd OCT intact ROS cells identical OH effect OCT osteocalcin secretion alkaline phosphatase ALP activity ROS cells Pretreatment OH OCT dose-dependent enhancement osteocalcin secretion stimulation compounds ALP activity incubation OH OCT compounds ALP activity extent Stimulation OCT VDR levels ALP activity osteocalcin secretion addition microM cycloheximide actions OCT new protein synthesis OCT OH vitamin receptor osteocalcin secretion ALP activity ROS cells analog active OH bone formation vivo low activity OCT calcium bone vivo due inability compound osteoblasts